The board approved Q3-FY26 unaudited results and announced a management reshuffle, elevating Navrattan Munjal and others to key MD roles, with remuneration decisions pending shareholder approval and a site relaunch to occur by March 2026.
AI Assistant
Ind-Swift Laboratories Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.